此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Simethicone on Colon Preparation During Water Exchange Colonoscopy

2026年6月23日 更新者:Dalin Tzu Chi General Hospital

Effects of Simethicone on Colon Preparation in Water Exchange Colonoscopies: a Randomized Controlled Study

Background: Colonoscopy reduces colorectal cancer mortality by enabling early detection and removal of adenomas. Its effectiveness, however, depends heavily on bowel preparation quality and mucosal visibility. Simethicone, an anti-foaming agent, decreases intraluminal bubbles and improves visualization; studies in conventional air-insufflation colonoscopy generally show benefits for cleanliness and patient comfort, but evidence in water-exchange (WE) colonoscopy remains limited.Objective: To evaluate whether adding oral simethicone to a split-dose polyethylene glycol (PEG) regimen further improves bowel cleanliness and procedural performance in WE colonoscopy.Methods: Adults undergoing outpatient colonoscopy will be randomly assigned (1:1) to a simethicone group or a control group, with a planned enrollment of 180 participants. All procedures will use the WE insertion technique, and endoscopists will be blinded to group allocation. The primary endpoint is the Boston Bowel Preparation Scale (BBPS); adequate preparation is defined as a total score ≥6 with all segment scores ≥2. Secondary endpoints include bubble score and CEBuS, adenoma detection rate (ADR), polyp detection rate (PDR), cecal intubation rate and time, withdrawal time, volume of water used and flushing/irrigation metrics, and patient-reported tolerability and satisfaction.Expected Results: Compared with PEG alone, adding simethicone is expected to (1) increase the proportion of adequate BBPS preparations, (2) reduce bubble coverage, (3) maintain or potentially improve ADR/PDR, and (4) enhance patient tolerability and satisfaction.Conclusion: If effective, this intervention would provide a simple, low-cost strategy to optimize the quality of WE colonoscopy.

研究概览

研究类型

介入性

注册 (估计的)

180

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Consecutive patients undergoing screening, surveillance, or diagnostic colonoscopy.
  • Procedures performed by participating endoscopists.
  • Ability to provide written informed consent.

Exclusion Criteria:

  • Colonoscopy performed using air insufflation or water immersion technique.
  • History of colorectal surgery (e.g., colectomy or colostomy).
  • Known or suspected colonic obstruction or severe stricture.
  • Requirement for inpatient bowel preparation.
  • Known allergy or hypersensitivity to simethicone.
  • Unable or unwilling to provide informed consent.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Without simethicone group
follow a bowel preparation protocol consisting of 10 mg of bisacodyl and 2 liters of PEG solution.
All participants followed a standardized bowel preparation protocol consisting of 10 mg of bisacodyl and 2 liters of PEG solution administered in a split-dose regimen.
实验性的:With simethicone group
Participants received a total of 30 mL of simethicone, with 15 mL added to each 1-liter dose of polyethylene glycol (PEG) solution in the split-dose regimen.
All participants followed a standardized bowel preparation protocol consisting of 10 mg of bisacodyl and 2 liters of PEG solution administered in a split-dose regimen. Participants in the simethicone group additionally received 30 mL of simethicone (600 mg), with 15 mL added to each 1-liter dose of PEG solution.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Boston bowel preparation scale (BBPS)
大体时间:At the time of colonoscopy.
Bowel preparation quality assessed using the Boston Bowel Preparation Scale (BBPS). Adequate preparation is defined as a total score ≥6 with all segment scores ≥2.
At the time of colonoscopy.

次要结果测量

结果测量
措施说明
大体时间
Bubble score assessed using a 4-point bubble scale
大体时间:During the colonoscopy procedure.
Bubble score assessed during colonoscopy using a 4-point scale (0-3) for each colon segment, where higher scores indicate more bubbles.
During the colonoscopy procedure.
Colon Endoscopic Bubble Scale(CEBuS)
大体时间:During the colonoscopy procedure.
Bowel cleanliness assessed using the Colon Endoscopic Bubble Scale (CEBuS), categorized based on the percentage of mucosal surface obscured by bubbles (e.g., <5%, 5-50%, >50%).Higher scores indicate poorer visibility due to bubbles.
During the colonoscopy procedure.
Adenoma detection rate (ADR)
大体时间:one week
one week
Polyp detection rate (PDR)
大体时间:one week
one week
Cecal intubation rate
大体时间:At the time of colonoscopy.
Proportion of procedures in which the cecum is successfully reached.
At the time of colonoscopy.
Cecal intubation time
大体时间:During the colonoscopy procedure.
Time from insertion to successful cecal intubation, measured in minutes.
During the colonoscopy procedure.
Withdrawal time
大体时间:During the colonoscopy procedure.
Time from cecal intubation to scope withdrawal, measured in minutes.
During the colonoscopy procedure.
Volume of water infused
大体时间:During the procedure.
Total volume of water infused during colonoscopy, measured in milliliters.
During the procedure.
Volume of fluid aspirated
大体时间:During the procedure
Total volume of fluid aspirated during colonoscopy, measured in milliliters.
During the procedure
Patient-reported pain score
大体时间:Immediately after the procedure.
Pain assessed using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst pain imaginable).
Immediately after the procedure.
Patient satisfaction score
大体时间:Immediately after the procedure.
Patient satisfaction assessed using a numeric rating scale from 0 to 10, where higher scores indicate greater satisfaction.
Immediately after the procedure.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2028年5月1日

研究完成 (估计的)

2028年9月1日

研究注册日期

首次提交

2026年3月3日

首先提交符合 QC 标准的

2026年6月23日

首次发布 (实际的)

2026年6月29日

研究记录更新

最后更新发布 (实际的)

2026年6月29日

上次提交的符合 QC 标准的更新

2026年6月23日

最后验证

2026年2月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅